SciSparc (OTCQB:SPRCY), formerly Therapix Biosciences, announced today that it closed a private placement worth $8.15 million. Tel Aviv, Israel-based SciSparc sold nearly 1.2 million units in the offering, with 916,316 units (consisting of 1 American Depositary Share, one Series A warrant to purchase an equal number of units purchased and one Series B warrant to […]
